Systematic Literature Review of Clinical and Economic Evidence for Spinal Muscular Atrophy

被引：0
|
作者：
Min Yang
Hiroyuki Awano
Satoru Tanaka
Walter Toro
Su Zhang
Omar Dabbous
Ataru Igarashi
机构：
[1] Analysis Group,Department of Pediatrics
[2] Inc.,Unit of Public Health and Preventive Medicine
[3] Kobe University Graduate School of Medicine,Department of Health Economics and Outcomes Research, Graduate School of Pharmaceutical Sciences
[4] Novartis Pharma K.K.,undefined
[5] Novartis Gene Therapies,undefined
[6] Inc.,undefined
[7] Yokohama City University,undefined
[8] The University of Tokyo,undefined
来源：
Advances in Therapy | 2022年 / 39卷
关键词：
Disease-modifying therapies; Economic burden; Gene therapy; Health-related quality of life; Humanistic burden; Natural history; Nusinersen; Onasemnogene abeparvovec; Spinal muscular atrophy; Systematic literature review;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1915 / 1958
页数：43
相关论文
共 50 条
  • [1] Systematic Literature Review of Clinical and Economic Evidence for Spinal Muscular Atrophy
    Yang, Min
    Awano, Hiroyuki
    Tanaka, Satoru
    Toro, Walter
    Zhang, Su
    Dabbous, Omar
    Igarashi, Ataru
    ADVANCES IN THERAPY, 2022, 39 (05) : 1915 - 1958
  • [2] Systematic literature review of the economic burden of spinal muscular atrophy and economic evaluations of treatments
    Dangouloff, Tamara
    Botty, Camille
    Beaudart, Charlotte
    Servais, Laurent
    Hiligsmann, Mickael
    ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [3] Systematic literature review of the economic burden of spinal muscular atrophy and economic evaluations of treatments
    Tamara Dangouloff
    Camille Botty
    Charlotte Beaudart
    Laurent Servais
    Mickaël Hiligsmann
    Orphanet Journal of Rare Diseases, 16
  • [4] Systematic Literature Review to Assess Economic Evaluations in Spinal Muscular Atrophy (SMA)
    Paracha, Noman
    Hudson, Pollyanna
    Mitchell, Stephen
    Sutherland, C. Simone
    PHARMACOECONOMICS, 2022, 40 (SUPPL 1) : 69 - 89
  • [5] Systematic literature review of the impact of spinal muscular atrophy therapies on bulbar function
    McGrattan, Katlyn
    Walsh, Katie
    Mehl, Lesa
    Kaur, Simarjeet
    Dilly, Keith W.
    JOURNAL OF NEUROMUSCULAR DISEASES, 2025, 12 (02) : 195 - 217
  • [6] Delay in Diagnosis of Spinal Muscular Atrophy: A Systematic Literature Review
    Lin, Chia-Wei
    Kalb, Stephanie J.
    Yeh, Wei-Shi
    PEDIATRIC NEUROLOGY, 2015, 53 (04) : 293 - 300
  • [7] A systematic review of economic evaluations of orphan medicines for the management of spinal muscular atrophy
    Belancic, Andrej
    Faour, Andrea Katrin
    Gkrinia, Elvira Meni Maria
    Vitezic, Dinko
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2025, 91 (01) : 95 - 116
  • [8] Review of economic modeling evidence from NICE appraisals of rare disease treatments for spinal muscular atrophy
    Wiedmann, Lea
    Cairns, John
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2023, 23 (05) : 469 - 482
  • [9] Current evidence for treatment with nusinersen for spinal muscular atrophy: a systematic review
    Antoon Meylemans
    Jan De Bleecker
    Acta Neurologica Belgica, 2019, 119 : 523 - 533
  • [10] Current evidence for treatment with nusinersen for spinal muscular atrophy: a systematic review
    Meylemans, Antoon
    De Bleecker, Jan
    ACTA NEUROLOGICA BELGICA, 2019, 119 (04) : 523 - 533
12345